bioAffinity’s AI Lung-Cancer Stock Jumped Nearly 48% After a Reverse Split. What Would Have to Go Right? - Yahoo Finance

bioAffinity’s AI Lung-Cancer Stock Jumped Nearly 48% After a Reverse Split. What Would Have to Go Right?    Yahoo Finance

Why it matters: RSS-imported item, awaiting editor or agent follow-up on market impact.